Avior Wealth Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-30
| Closed | -$1.97K | – | 930 |
|
2024
Q4 | $1.97K | Hold |
30
| – | – | ﹤0.01% | 2119 |
|
2024
Q3 | $2.11K | Hold |
30
| – | – | ﹤0.01% | 1968 |
|
2024
Q2 | $2.47K | Sell |
30
-341
| -92% | -$28.1K | ﹤0.01% | 1902 |
|
2024
Q1 | $32.4K | Buy |
+371
| New | +$32.4K | ﹤0.01% | 1403 |
|
2020
Q1 | – | Sell |
-49
| Closed | -$4K | – | 775 |
|
2019
Q4 | $4K | Buy |
49
+40
| +444% | +$3.27K | ﹤0.01% | 661 |
|
2019
Q3 | $0 | Buy |
+9
| New | – | ﹤0.01% | 784 |
|
2019
Q1 | – | Sell |
-1,081
| Closed | -$92K | – | 652 |
|
2018
Q4 | $92K | Hold |
1,081
| – | – | 0.02% | 438 |
|
2018
Q3 | $105K | Hold |
1,081
| – | – | 0.02% | 432 |
|
2018
Q2 | $102K | Sell |
1,081
-13
| -1% | -$1.23K | 0.02% | 439 |
|
2018
Q1 | $89K | Sell |
1,094
-74
| -6% | -$6.02K | 0.02% | 449 |
|
2017
Q4 | $104K | Buy |
+1,168
| New | +$104K | 0.02% | 442 |
|